Faculty members

Simona Balestrini

Simona Balestrini is Associate Professor of Child Neurology and Psychiatry at the Neuroscience Department, Children's Hospital A. Meyer, and the University of Florence. She is also a Consultant Neurologist at the Chalfont Centre for Epilepsy and National Hospital for Neurology and Neurosurgery, UCLH, and Senior Clinical Research Fellow at UCL Queen Square Institute of Neurology. She has a special interest in epilepsy genetics and runs epilepsy clinics and epilepsy genomics clinics in Italy and United Kingdom. Her current research focuses on the application of next-generation sequencing techniques to understand the causes, course and treatment response of epilepsy, with the ultimate aim to translate the findings directly into personalised treatment.

 

 

  Nihan Carcak

Nihan Çarçak is Associate Professor of Pharmacology at Istanbul University Faculty of Pharmacy. She is focus on translational epilepsy research investigating the mechanistic inter-relationship between generalised seizures of thalamocortical origin, in the context of interactions of cortex and thalamus underlying absence epilepsy. She is the member of International League Against Epilepsy, Young Neurobiologist Task Force since 2018. Through her publications, presentations, academic visits she has already built a reputation as one of the young promising neuroscientist in the field of translational research for epilepsy.

 

 

Drahomira Dvorakova

Drahomira Dvorakova, MSc. is the Head of the Department for Scientific Information at the Second Faculty of Medicine, Charles University. In her work, she is oriented on e-learning and the implementation of innovative pedagogic techniques to the education of medical students.

 

 

Marian Galovic

Marian Galovic is Head of the Epilepsy Unit at the University Hospital Zurich, Switzerland. His research focuses on neuroimaging and prognostic models in epilepsy. He is the Past-Chair of the ILAE Young Epilepsy Section.

 

 

Vadym Gnatkovsky

Vadym Gnatkovsky is a Senior Researcher at the Department of Epileptology, University Hospital Bonn, Germany. He holds a PhD in medicine. His scientific interest addressed basic mechanisms underlying epileptic seizure development in experimental and human epilepsy as well as the identification and quantification of EEG biomarkers of the epileptogenic zone. Ongoing studies compare EEG data from epilepsy animal models (potential mechanisms of seizure generation) with human intracranial SEEG recordings. Aim of this work is studying intrinsic mechanisms of seizure generation, development end termination. He has been a member of the AES/ILAE’s Translational Task Force.

 

 

Gilles Huberfeld

Gilles Huberfeld, MD, PhD, is both an epileptologist / electrophysiologist (Hopital Fondation Adolphe de Rothschild, Paris, France) and a researcher (Center for Interisciplinary Research in Biology, College de France, Paris). His research aims at identifying electrophysiological signature of brain processes and at studying epilepsy mechanisms and interactions between epilepsy and brain lesions at the neuronal level.

 

 

Shilpa D. Kadam

Shilpa D. Kadam is Associate Professor of Neurology at the Kennedy Krieger Institute and Johns Hopkins University School of Medicine located in Baltimore, Maryland, USA. She is the founder and director of the preclinical EEG core. Her expertise is in epilepsy and mechanisms of epileptogenesis with a sharp focus on neurodevelopmental disorders and refractory seizures.

 

 

Katja Kobow

Katja Kobow is a biochemist and Assistant Professor at the Dept of Neuropathology, University Hospital Erlangen, FAU Erlangen, Germany. She is a distinguished expert in molecular neuropathology and epilepsy. She has focused her work on the role of epigenetics in the pathogensis of epilepsy as well as the use of epigenetic signatures as molecular diagnostic biomarker in structural brain lesions associated with focal epilepsy. In 2021 she was awarded the prestigous Michael Prize for her outstanding and pioneering research. Katja is further one of the founding members and previous board member of the ILAE’s Young Epilepsy Section, where she is organizing peer-2peer mentoring programs and educational activities for young epileptologists in both clinic and basic research. 

 

 

Gabriele Lignani

Gabriele Lignani is an Associate Professor at UCL Queen Square Institute of Neurology. The main focus of his lab is to develop gene therapy and editing techniques to treat intractable neurological diseases, to study the role of homeostatic plasticity in epilepsy and to understand the basic epileptic mechanisms. In 2021 He has been awarded the Harinarayan Young Scientist Award by ILAE Neurobiology committee for his research in gene therapy for intractable focal epilepsies.

 

 

Christos Lisgaras

Christos Lisgaras is an Assistant Research Scientist at the New York University and The Nathan Kline Institute Center for Dementia Research. His expertise is in many different types of epilepsy including developmental, post-traumatic and epilepsy in Azheimer’s disease. His current work is focusing on developing novel approaches to study and treat epilepsies and dementias in animal models. Christos is also one of ILAE’s Young Epilepsy Section founding members and previous Vice-Chairperson.   

 

 

Massimo Mantegazza

Massimo Mantegazza is Inserm Research Director and Group Leader at the Institute of Molecular and Cellular Pharmacology (CNRS and University Cote d’Azur, Nice, France). His research activity is focused on the pathophysiology of ion channels and of neuronal excitability involved in epilepsy and other diseases of the central nervous system, with the goal to understand pathological mechanisms and develop innovative therapeutic strategies. 

 

 

Petr Marusic

Petr Marusic is Professor of Neurology and the Head of the Department of Neurology at the Second Faculty of Medicine, Charles University and Motol University Hospital. Currently, he is the President of the Czech Neurological Society. In his research, he focuses on epilepsy surgery, analysis of intracranial EEG, neuroimaging, and cognitive aspects of epilepsy. 

 

 

Jakub Otahal

Jakub Otahal is a Professor at the Department of Developmental Epileptology of the Czech Academy of Sciences and Head of the NeuroImaging group of Epilepsy Research Center of Prague. He focuses on metabolic and inflammatory changes in epileptogenic tissue and on translating knowledge from basic science to clinical practice namely to improve the yield of neuroimaging techniques. 

 

 

Julika Pitsch

Julika Pitsch is a Principal Investigator in the Department of Epileptology at University Hospital Bonn, Germany and head of the working group “Immune-mediated Epilepsies”. She is also the leader of the Transgenic mouse platform with permanent EEG/video Monitoring Unit. Her research interests are related to neuroimmunology, molecular neuroscience and experimental neuropathology. Her expertise includes analyzing transgenic and induced epilepsy animal models, in vivo models for limbic encephalitis, EEG measurements, histology, and additional molecular and functional analyses.

 

 

Cristina R. Reschke

Cristina R. Reschke is Lecturer in the School of Pharmacy and Biomolecular Sciences and Funded Investigator within FutureNeuro Research Centre at RCSI University of Medicine and Health Sciences, Ireland. She trained as Clinical Pharmacist and holds MSc and PhD in Pharmacology, which were focused on epilepsy treatment. Cristina major discoveries are on microRNA-based therapies and the pre-clinical development of novel oligonucleotide delivery systems. She specifically focus on uncovering cellular and molecular mechanisms underlying epilepsy to allow for the development of novel and precise therapeutic approaches for disease-modification.  

 

 

Erwin van Vliet

Erwin van Vliet is assistant professor at the Center for Neuroscience, University of Amsterdam and senior scientist at the Academic Medical Center in Amsterdam, the Netherlands. Using in vitro and in vivo preclinical epilepsy models and brain tissue from patients with epilepsy, he seeks to unravel the mechanisms of drug-resistance and epileptogenesis, to find biomarkers, and to apply novel therapeutic strategies. His main focus is on the neurovascular unit.